Breast cancer treatment depends on the stage of the cancer, its biology and your health. Many people with early breast cancer have surgery first, while locally advanced breast cancer often requires medicines before surgery. In metastatic breast cancer, medicines that act throughout the body are usually the main treatment, with radiation or surgery used for specific needs. www.cancer.gov
By Dr Raman Narang, Consultant Medical & Hemato-Oncologist
Two people diagnosed with breast cancer in the same week may receive very different plans. One may be advised to have surgery, then take hormone-blocking tablets. Another may be advised to start chemotherapy before an operation. The difference often comes down to a question that matters early on: What do we gain by starting with one treatment before the other? www.cancer.gov
1. If I have early breast cancer, should I have breast surgery first?
Early invasive breast cancer includes stage I and some stage II cancers. For many patients with a smaller, operable cancer, breast surgery comes first, with treatment planned with the aim of cure. The operation may be breast-conserving surgery, which removes the tumour with a rim of surrounding tissue, or mastectomy, which removes the breast. The choice depends on the size and location of the tumour, the areas of the breast involved, whether radiation is feasible and your preferences. For appropriately selected patients, breast-conserving surgery followed by radiation offers survival comparable to mastectomy. www.cancer.gov
The final pathology report gives the team more information about the tumour and any lymph nodes removed. Chemotherapy in early breast cancer is recommended when the expected reduction in recurrence risk justifies the side effects. For selected patients with hormone receptor-positive, HER2-negative breast cancer, a tumour genomic assay may help estimate whether chemotherapy would add benefit to endocrine therapy. Whether the test is useful depends on factors such as menopausal status and lymph node involvement. Before paying for it, ask whether the result could change your treatment plan. ascopubs.org
Some patients with higher-risk HER2-positive or triple-negative breast cancer benefit from starting medicines first, even when surgery is technically possible. How much cancer remains at surgery can help guide which medicines are offered afterwards. pmc.ncbi.nlm.nih.gov
2. Why might locally advanced breast cancer need chemotherapy before surgery?
Locally advanced breast cancer generally includes stage III and some stage II cancers. The cancer may involve the breast skin, chest wall or nearby lymph nodes, with no evidence of spread to distant organs. Treatment is often still planned with the aim of cure. www.cancer.gov
Treatment often starts with medicines before surgery. When chemotherapy is given at this point, it is called neoadjuvant chemotherapy. Depending on the subtype, the plan may include HER2-targeted therapy or, for eligible patients with triple-negative breast cancer, immunotherapy. Treatment before surgery can shrink the tumour, make an operation possible or less extensive in some cases, and show how the cancer responds. The operation still needs to be planned around the original extent of the cancer and the response to treatment. www.cancer.gov
After surgery, the pathology report helps the team decide whether further medicines are appropriate. Breast or chest wall radiation, often including nearby lymph node areas, is commonly part of the plan. If you expect to receive chemotherapy, surgery and radiation at different centres, ask who will coordinate the handovers and which reports each team will need. www.cancer.gov
3. How is metastatic breast cancer treated?
Metastatic breast cancer, also called stage IV breast cancer, has spread to distant parts of the body such as the bones, liver, lungs or brain. Treatment generally aims to control the cancer, help you live longer, relieve symptoms and preserve quality of life. If a metastatic site can be safely biopsied, the team may recommend doing so to confirm the diagnosis and reassess ER, PR and HER2, because these markers can differ from the original breast tumour. annalsofoncology.org
For many patients with hormone receptor-positive, HER2-negative metastatic disease, endocrine therapy combined with a targeted medicine called a CDK4/6 inhibitor is an initial option. HER2-positive disease is generally treated with HER2-directed medicines. Chemotherapy in metastatic breast cancer may be appropriate depending on the subtype, previous treatment, symptoms and how urgently the cancer needs to be controlled. The oncology team also considers what matters most to you, such as maintaining daily activities or reducing the burden of hospital visits. annalsofoncology.org
Radiation can relieve pain from a bone metastasis or treat selected brain metastases. Surgery may help with specific problems, such as symptoms from a breast or chest wall tumour. In the EA2108 randomised trial, routinely adding early surgery and radiation to the breast in patients who first presented with stage IV disease did not improve overall survival. If an operation is proposed, ask what it is intended to achieve in your situation. pmc.ncbi.nlm.nih.gov
4. When is breast radiation therapy needed?
Breast radiation therapy is usually recommended after breast-conserving surgery to reduce the chance of cancer returning in the treated breast. Selected patients with a low risk of recurrence may discuss omitting it. After mastectomy, the recommendation depends on factors such as the initial extent of the cancer, lymph node involvement and, when medicines were given before surgery, the findings at surgery. Both the original stage and the response to treatment can matter. NCI
If you are deciding between breast conservation and mastectomy, ask about radiation before choosing an operation. Understanding which areas may need treatment and how many visits the proposed schedule involves can help you plan around work, caregiving and travel across Delhi NCR. American Society for Radiation Oncology (ASTRO)
5. What should I bring to a breast cancer treatment consultation in Delhi?
What I look for clinically
I first check whether the biopsy, examination and imaging tell a consistent story. I look at the tumour size and location, the lymph nodes, the tumour grade and the ER, PR and HER2 results. I then ask whether starting medicines first could improve the surgical options or give us information that would change treatment after surgery. If an important result is unclear, I identify what needs review and whether it could change the immediate plan. pmc.ncbi.nlm.nih.gov
An if–then map for the first treatment decision
| If the assessment shows… | Then the team usually discusses… |
|---|---|
| A smaller, operable cancer with no clear advantage to starting medicines first | Surgery first, followed by a review of the final pathology to plan further treatment. |
| Higher-risk HER2-positive or triple-negative disease, or locally advanced disease without distant spread | Medicines before surgery, with the regimen guided by subtype and the next steps informed by response. |
| Confirmed distant spread | Medicines that act throughout the body, with radiation or surgery considered for specific symptoms or local problems. |
These are starting points for a multidisciplinary discussion. The exact sequence depends on the full clinical assessment. www.cancer.gov
Patient checklist
- Bring the biopsy report, including ER, PR and HER2 results and any addenda.
- Carry reports and image files from breast imaging and any staging scans already performed.
- If you have had breast surgery, bring the operative note and final pathology report.
- Bring a list of prior cancer medicines and radiation, with treatment dates if available.
- List your current medicines, major health conditions and any treatment side effects.
- Mention any family history of cancer and bring previous genetic test results if available.
- Write down the decision you need help with and any practical concerns about costs, travel or time away from work.
6. What else should I know before starting treatment?
Do all patients with breast cancer need chemotherapy?
The need for chemotherapy depends on stage, subtype, recurrence risk, overall health and the expected benefit. Some patients with early hormone receptor-positive, HER2-negative breast cancer can receive endocrine therapy without chemotherapy. ascopubs.org
Does cancer in an underarm lymph node mean stage IV?
Underarm lymph nodes on the same side as the breast cancer are regional lymph nodes. Their involvement affects staging and treatment planning. Stage IV means the cancer has spread to a distant site. NCI
Can I still need surgery if the tumour disappears on scans after chemotherapy?
Surgery usually remains part of treatment when the aim is cure. Imaging can show how much the tumour has shrunk, while examining the tissue removed at surgery helps determine whether any invasive cancer remains. pmc.ncbi.nlm.nih.gov
Does having a mastectomy mean I can avoid radiation?
Some patients can. Others benefit from radiation after mastectomy, particularly when the cancer initially involved a larger area or when lymph nodes are involved. Ask the radiation oncologist how the findings in your case affect that recommendation. American Society for Radiation Oncology (ASTRO)
Closing perspective
Before starting treatment, ask your team to put three things in writing: the goal, the first step and the finding that could change the next step. If you have received different recommendations about chemotherapy first or surgery first, a focused second opinion can clarify which features of your biopsy and scans are driving each recommendation and help you make a timely decision.
This article provides general education. Your oncology team can recommend a treatment plan after reviewing your reports, examining you and discussing your preferences.
References for editorial verification
- National Cancer Institute. Breast Cancer Treatment by Stage and Breast Cancer Treatment (PDQ®), Health Professional Version.
- ASCO. Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer and Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer.
- ASTRO, ASCO and SSO. Postmastectomy Radiation Therapy Clinical Practice Guideline.
- ESMO. Metastatic Breast Cancer Clinical Practice Guideline for Diagnosis, Treatment and Follow-up.
- Khan SA et al. EA2108 Randomised Trial of Early Local Therapy in De Novo Stage IV Breast Cancer.